State deregulation and Medicare costs for acute cardiac care

Vivian Ho1, Meei-Hsiang Ku-Goto

  • 1Baker Institute for Public Policy, Rice University, Houston, TX 77005, USA. vho@rice.edu

Insights

Certificate of Need (CON) regulations for cardiac surgery did not improve quality and increased patient costs. Deregulation led to lower costs for coronary artery bypass graft (CABG) surgery, suggesting CON laws may not be justified.

Area of Science:

  • Health Economics
  • Healthcare Policy
  • Cardiac Surgery Outcomes

Background:

  • Certificate of Need (CON) regulations are debated for their impact on healthcare quality and costs.
  • Previous research indicates CON laws for cardiac care did not enhance quality.
  • The effect of CON regulations on patient costs remains less understood.

Purpose of the Study:

  • To analyze the impact of dropping CON regulations on patient costs and Medicare reimbursements for specific cardiac procedures.
  • To determine if states removing CON for cardiac care experienced changes in costs for Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Interventions (PCI).

Main Methods:

  • Analysis of Medicare data spanning from 1991 to 2002.
  • Comparison of costs and reimbursements for CABG and PCI in states with and without CON regulations.
  • Evaluation of the financial balance between cost savings and fixed costs of new facility entry post-deregulation.

Main Results:

  • States that eliminated CON regulations saw lower per-patient costs for CABG surgery, but not for PCI.
  • Average Medicare reimbursements decreased for both CABG and PCI in states that dropped CON.
  • Cost savings from CON deregulation for CABG surgery exceeded the fixed costs of newly established facilities.

Conclusions:

  • CON regulations for CABG surgery may not be justifiable based on quality improvements or cost control.
  • Deregulation of CON for CABG surgery demonstrated potential for cost savings.
  • The findings suggest a re-evaluation of CON laws in the context of cardiac care cost-effectiveness.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...